Diabetes Management: Remission, Myths, and Rising Trends

On National Diabetes Day, Dr. Kelvin Candiago, M.M., MARS, DABRM, introduced the 3R Protocol as a structured approach to achieving remission in type 2 diabetes mellitus, emphasizing that remission is an achievable target through integrated care strategies.

The 3R Protocol focuses on three core components: reducing insulin resistance, restoring beta-cell function, and reinforcing sustainable lifestyle changes, aligning with current evidence that highlights metabolic surgery, intensive lifestyle interventions, and pharmacological agents like GLP-1 receptor agonists and tirzepatide as promising options for remission, particularly when applied early in the disease course.

Remission of type 2 diabetes is defined by a recent consensus report from the Endocrine Society, the European Association for the Study of Diabetes, Diabetes UK, and the American Diabetes Association as achieving and maintaining glycated haemoglobin levels below 48 mmol/mol (6.5%) for at least three months without the use of glucose-lowering medications.

This definition underscores that remission is not merely temporary improvement but a sustained metabolic state, offering benefits such as reduced morbidity, improved quality of life, and preservation of beta-cell function, which are critical in preventing long-term complications associated with hyperglycaemia-induced metabolic memory.

Metabolic surgery demonstrates the most significant impact on long-term remission outcomes, inducing profound hormonal changes including increased glucagon-like peptide-1 (GLP-1) levels and improved bile acid metabolism, alongside reductions in ectopic fat in the liver and pancreas, which enhance insulin sensitivity and secretion.

However, intensive lifestyle interventions and pharmacological treatments, particularly GLP-1 receptor agonists and dual GLP-1/GIP agonists like tirzepatide, also show strong promise in driving remission, especially when implemented early, reinforcing the importance of a multidisciplinary and patient-centred approach to diabetes management.

These findings reflect a growing recognition that type 2 diabetes remission is not a dream but an achievable reality for many patients, provided that care strategies are timely, comprehensive, and supported by ongoing medical supervision and patient engagement.